CHRN vs SLVM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CHRN · ChronoScale$10.75 ▲ 5.81%
SLVM · Sylvamo$39.38 ▲ 19.08%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CHRN +115.0%
- SLVM -3.8%
Head to head
| Metric | CHRN | SLVM |
|---|---|---|
| Price | $10.75 | $39.38 |
| Change today | ▲ 5.81% | ▲ 19.08% |
| Market cap | $1.57B | $1.57B |
| Return, 3 months | -44.6% | -0.9% |
| Return, year to date | +24.4% | -14.4% |
| Return, 1 year | +130.2% | -4.3% |
| P/E (TTM) | – | 21.1 |
| P/B | 10.4 | 1.6 |
| P/E percentile vs own 5y | 8th | 88th |
| Dividend yield | – | 5.71% |
| Revenue growth (YoY, latest qtr) | +148.1% | +1.5% |
| Net profit growth (YoY) | -277.9% | -173.3% |
| Gross margin | -14.6% | 20.6% |
| Operating margin | -56.3% | 5.8% |
| Net margin | -84.6% | 2.3% |
| Return on equity | -54.1% | 7.9% |
| Analyst target vs. price | +165.1% | +4.1% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 32 | 71 |
| 30-day volatility | 110.7% | 66.1% |
| Max drawdown, 1 year | -65.7% | -41.0% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SLVM is the largest of the group by market value.
- CHRN has returned the most over the past year.
- CHRN is growing revenue fastest.
- SLVM keeps the most profit per dollar of sales.
- SLVM has been the calmest stock over the last 30 days.